Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma
Clinical trial NCT00532389 · COMPLETED
Trial details
- NCT number
- NCT00532389
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2013-10-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.